SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-145337
Filing Date
2019-05-13
Accepted
2019-05-13 16:07:03
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d704561d10q.htm 10-Q 820450
2 EX-31.1 d704561dex311.htm EX-31.1 11001
3 EX-31.2 d704561dex312.htm EX-31.2 11001
4 EX-32.1 d704561dex321.htm EX-32.1 5530
  Complete submission text file 0001193125-19-145337.txt   3475388

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT avro-20190331.xml EX-101.INS 513316
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20190331.xsd EX-101.SCH 45273
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20190331_cal.xml EX-101.CAL 47690
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20190331_def.xml EX-101.DEF 115893
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20190331_lab.xml EX-101.LAB 339921
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20190331_pre.xml EX-101.PRE 238129
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 19818434
SIC: 2836 Biological Products, (No Diagnostic Substances)